Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer ; volume:72 ; number:10 ; day:1 ; month:8 ; year:2023 ; pages:3135-3147 ; date:10.2023
Cancer immunology immunotherapy ; 72, Heft 10 (1.8.2023), 3135-3147, 10.2023
- Creator
-
Veen, Torhild
Kanani, Arezo
Lea, Dordi
Søreide, Kjetil
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03480-w
- URN
-
urn:nbn:de:101:1-2023112112005494690253
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Veen, Torhild
- Kanani, Arezo
- Lea, Dordi
- Søreide, Kjetil
- SpringerLink (Online service)
Other Objects (12)
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Total neoadjuvant therapy for each locally advanced rectal cancer?
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?)
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas
Timing of neoadjuvant therapy and surgical treatment in rectal cancer
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Total neoadjuvant therapy for each locally advanced rectal cancer?
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?)
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas
Timing of neoadjuvant therapy and surgical treatment in rectal cancer
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Total neoadjuvant therapy for each locally advanced rectal cancer?
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?)
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas